Mara A. Schonberg|Erica S. Breslau|Ellen P. McCarthy
Targeting of Mammography Screening According to Life Expectancy in Women Aged 75 and Older
Beth Israel Deaconess Medical Center|Harvard University|National Institutes of Health|National Cancer Institute|Beth Israel Deaconess Medical Center|Harvard University
objectives examine receipt mammography screening according life expectancy women aged 75 older design populationbased survey setting united states participants community dwelling us women aged 75 older participated 2008 2010 national health interview survey measurements using previously developed validated index women categorized according life expectancy gt9 59 lt5 years receipt mammography screening past 2 years examined according life expectancy adjusting sociodemographic characteristics access care preventive orientation eg receipt influenza vaccination receipt clinician recommendation screening results 2266 respondents 271 life expectancy greater 9 years 534 life expectancy 5 9 years 195 life expectancy less 5 years overall 557 reported receiving mammography screening past 2 years life expectancy strongly associated receipt screening p lt 001 yet 361 women less 5 years life expectancy screened 292 women 9 years life expectancy screened clinician recommendation screening strongest predictor screening independent life expectancy higher educational attainment age receipt influenza vaccination history benign breast biopsy also independently associated screened conclusion despite uncertainty benefit many women aged 75 older screened mammography life expectancy strongly associated receipt screening may reflect clinicians patients appropriately considering life expectancy screening decisions 36 women short life expectancies still screened suggesting new interventions needed improve targeting screening according life expectancy decision aids guidelines encouraging clinicians consider patient life expectancy screening decisions may improve care